{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-242643","form_type":"8-K","ticker":"OACC","cik":"0002029769","company_name":"Oaktree Acquisition Corp. III Life Sciences","filed_at":"2025-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.385990+00:00","generated_at":"2026-05-17T03:27:38.887227+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as independent director","bullets":["Appointed Oct 17, 2025 as Class II director on audit, nominating, and compensation committees; deemed independent under Nasdaq and Rule 10A-3.","Co-founder & Managing Partner of Averin Capital (since May 2025); former Partner/GP at Flagship Pioneering (2005-2025); founder/CEO of Valo Health.","No cash compensation; eligible to invest non-controlling minority interest in Oaktree Acquisition Holdings III LS, consistent with other independent directors.","Will execute standard Letter Agreement and Indemnity Agreement on same terms as directors/officers from IPO."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-242643","json":"https://secwatch.observer/filing/0001193125-25-242643.json","markdown":"https://secwatch.observer/filing/0001193125-25-242643.md","text":"https://secwatch.observer/filing/0001193125-25-242643.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2029769/000119312525242643/0001193125-25-242643-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2029769/000119312525242643/d41718d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:27:38.887227+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}